Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

Biotechnology

Education

Sonoma Biotherapeutics

Sonoma Biotherapeutics' headquarters in South San Francisco, CA, United States

Jeff Bluestone

Jimmy Chung

Melisa S. Medrano

Jessica Stitt

Peter Dilaura

Doug Sheehy

Fred Ramsdell

Scientific Research Team

Leadership Team

Clinical Operations Team

Finance and Accounting Team

Legal and Compliance Team

Sonoma Biotherapeutics

Org chart

Teams

Scientific Research Team

Leadership Team

Clinical Operations Team

Finance and Accounting Team

Legal and Compliance Team

Offices

Similar companies